Dr. Heidi Noels and Dr. Yvonne Döring receive the W.H. Hauss Award from the DGAF
19-21 April 2018
Dr. Heidi Noels from the Institute for Molecular Cardiovascular Research at RWTH Aachen University together with Dr. Yvonne Döring from the Institute for Prophylaxis and Epidemiology of Circulatory Diseases at LMU Munich together received the DGAF W.H. Hauss Award 2018 from the German Society for Atherosclerosis Research (DGAF) during the 32nd Annual Meeting of the DGAF in Rauischholzhausen, Germany. They were awarded for their publication "Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence From Mouse and Human Studies." (Circulation. 2017; 136: 388-403). In this work it could be shown that vascular CXCR4 has an atheroprotective function by maintaining the arterial integrity and preserving the endothelial barrier function. In addition, CXCR4 stabilizes a contractile smooth muscle cell phenotype. Targeted enhancement of these CXCR4-mediated protective functions could open up novel therapeutic options in the treatment of atherosclerosis.
The award was sponsored by a long-standing active member of the DGAF, Prof. Dr. Winfried März.
Project area Z
Administrative project
Robert Werner Mertens
MD student
University Hospital RWTH Aachen
Department of Internal Medicine
Project: The role of incretin hormone GLP-2 in septic cardiomyopathy
PI: Michael Lehrke
Robert Werner Mertens
MD student
University Hospital RWTH Aachen
Department of Internal Medicine
Project: The role of incretin hormone GLP-2 in septic cardiomyopathy
PI: Michael Lehrke
Consortium
Mechanisms of Cardiovascular Complications
in Chronic Kidney Disease
The SFB/TRR219 is supported by the German Research Foundation (DFG)
Project-ID 322900939
Patients
SFB/TRR219 cooperates with the German patient organisation for kidney disease “Bundesverband Niere e.V.”
May 4th 2018
The SFB/TRR219 consortium, funded by the German Research Foundation, has initiated a cooperation with the German patient organisation for patients with kidney disease (“Bundesverband Niere e.V.”) with the aim to create new synergies between research and the patient organisation and to increase the involvement of patients from basic research to realization of innovating therapy ideas.
This cooperation was formalized by a letter of intent signed by
-Peter Gilmer, chair of the “Selbsthilfenetzwerk Bundesverband Niere e.V.” and representing the „Patientenstiftung Aktion Niere“;
-Martin Koczor, Managing Director of the “Bundesverband Niere e.V”
-Prof. Jankowski (speaker of the SFB/TRR219 and Head of the Institute for Molecular Cardiovascular Research, RWTH Aachen);
-Prof. Fliser (vice speaker of the SFB/TRR219 and Head of the Nephrology Department, Saarland University Hospital);
-Prof. Marx (Head of the Cardiology Department RWTH Aachen University);
and Prof. Floege (Head of the Nephrology Department RWTH Aachen University).
A publication in the patient journal “der Nierenpatient” accompanied this letter of intent to enhance awareness among patients with chronic kidney disease
